ROS-Responsive Nanoparticle as a Berberine Carrier for OHCTargeted Therapy of Noise-Induced Hearing Loss
ROS-Responsive Nanoparticle as a Berberine Carrier for OHCTargeted Therapy of Noise-Induced Hearing Loss
复制标题
ROS 响应纳米颗粒作为小檗碱载体用于 OHCT 噪声性听力损失靶向治疗
DOI:
10.1021/acsami.0c21151
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
刘洪梅
中科院分区:
文献类型:
--
作者:
赵泽祺;韩正中;Konduru Naveena;雷冠雄;邱士伟;李轩毅;李婷;时晰;庄伟;李雅兰;乔月华;刘洪梅
Overproduction of reactive oxygen species (ROS) and inflammation are two key pathogeneses of noise-induced hearing loss (NIHL), which leads to outer hair cell (OHC) damage and hearing loss. In this work, we successfully developed ROS-responsive nanoparticles as berberine (BBR) carriers (PLPPS/BBR) for OHC-targeted therapy of NIHL: Prestin-targeting peptide 2 (PrTP2)-modified nanoparticles (PL-PPS/BBR), which effectively accumulated in OHC areas, and poly(propylene sulfide)120 (PPS120), which scavenged ROS and converted to poly(propylene sulfoxide)120 in a ROS environment to disintegrate and provoke the rapid release of BBR with anti-inflammatory and antioxidant effects. In this study, satisfactory anti-inflammatory and antioxidant effects of PL-PPS/BBR were confirmed. Immuno-fluorescence and scanning electron microscopy (SEM) images showed that PL-PPS/BBR effectively accumulated in OHCs and protected the morphological integrity of OHCs. The auditory brainstem response (ABR) results demonstrated that PL-PPS/BBR significantly improved hearing in NIHL guinea pigs after noise exposure. This work suggested that PL-PPS/BBR may be a new potential treatment for noise-associated injury with clinical application.